Intelligent Bio Solutions Inc.
INBS
$1.41
$0.129.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.87% | 23.21% | 55.28% | 147.58% | 247.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.87% | 23.21% | 55.28% | 98.43% | 137.17% |
| Cost of Revenue | -44.19% | -24.60% | 10.30% | 81.27% | 303.93% |
| Gross Profit | 161.81% | 204.22% | 175.56% | 336.50% | 138.12% |
| SG&A Expenses | -2.04% | 4.26% | -3.13% | 15.35% | 27.82% |
| Depreciation & Amortization | 9.73% | 3.64% | -6.30% | 24.26% | 36.28% |
| Other Operating Expenses | -32.39% | -0.38% | 17.75% | 42.41% | 49.59% |
| Total Operating Expenses | 2.72% | 14.26% | 15.87% | 38.18% | 48.76% |
| Operating Income | -2.40% | -11.98% | -7.57% | -21.89% | -28.25% |
| Income Before Tax | -2.29% | 20.09% | 12.03% | 4.44% | 0.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.29% | 20.09% | 12.03% | 4.44% | 0.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.25% | 6.38% | 5.25% | 3.65% | 16.78% |
| Net Income | -2.31% | 20.16% | 12.08% | 4.47% | 0.20% |
| EBIT | -2.40% | -11.98% | -7.57% | -21.89% | -28.25% |
| EBITDA | -1.59% | -12.82% | -7.41% | -41.50% | -128.47% |
| EPS Basic | 93.81% | 96.73% | 95.42% | 85.79% | 67.51% |
| Normalized Basic EPS | 93.72% | 94.42% | 92.35% | 77.15% | 50.81% |
| EPS Diluted | 93.81% | 96.73% | 95.42% | 85.79% | 67.51% |
| Normalized Diluted EPS | 93.72% | 94.42% | 92.35% | 77.15% | 50.81% |
| Average Basic Shares Outstanding | 415.49% | 904.06% | 2,014.57% | 1,769.44% | 1,039.61% |
| Average Diluted Shares Outstanding | 415.49% | 904.06% | 2,014.57% | 1,769.44% | 1,039.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |